Presepsin levels in ascites fluid in liver failure
Part of Digestive system clinical trials.
This study is testing whether a blood test for presepsin (a protein that can show infection) can help predict infection in the belly fluid of people with chronic liver failure and ascites. If you have ascites and liver failure, this trial may help doctors better spot infections early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ascites (fluid in the belly) and chronic liver failure.
- You are 18 years or older.
- Your doctor says you can safely have a paracentesis (a procedure to remove fluid from your belly).
- You are willing to give informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what types of infections happen in people with severe hepatitis (liver failure). It aims to help doctors better understand and treat these infections. You may qualify if you have a long-term hepatitis B or recent hepatitis E infection and your liver function has gotten much worse quickly.
This trial looks at genetic markers to better predict sepsis after major abdominal surgery. It may help find patients at higher risk so they can be treated earlier.
This trial looks at whether simple blood tests (platelet count, sodium, and a liver score) can predict a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis and fluid buildup in the belly (ascites). If successful, it could help doctors catch this infection earlier.
This study tests a new scoring system to predict a serious infection called spontaneous bacterial peritonitis (SBP) in people with liver cirrhosis and fluid buildup in the belly (ascites). It aims to help catch the infection early so treatment can start sooner.
This study looks for signs that predict a bacterial infection in the belly fluid of people with liver cirrhosis. It aims to catch infection early and improve treatment for patients with ascites.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
Hear when a new Ascites Hepatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.